logo

For the Inventor, By the Inventor

Denver, CO, United States of America

Cleerly, Inc.


USPTO Granted Patents = 71


Trademarks = 2

Forward Citations = 1,761

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal James K Min (70 out of 80 patents)

silverMedal James P Earls (59 out of 59 patents)

bronzeMedal Hugo Miguel Rodrigues Marques (57 out of 57 patents)

4.  Ben Hootnick (21 out of 21 patents)

5.  Shant Malkasian (12 out of 12 patents)

6.  Shai Ronen (6 out of 30 patents)

7.  Chung Chan (6 out of 6 patents)

8.  Tami Crabtree (1 out of 1 patent)

9.  Hugo Miguel Rodrigues Marques (1 out of 1 patent)


Core Competencies:
Plaque Analysis
Risk Determination
Medical Imaging
Image Diagnosis
Risk Stratification
Disease Tracking
High Risk Plaques
Decision Making
Non-Invasive Techniques
Image-Based Systems
Diagnostic Devices
Medical Systems

71 patents:

1. 12714382 - Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination (2026-08-25),
2. 12712082 - SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE IMAGE-BASED PLAQUE ANALYSIS AND RISK DETERMINATION (2026-08-18),
3. 12635965 - Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination (2026-05-26),
4. 12620092 - Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination (2026-05-05),
5. 12599352 - Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination (2026-04-14),
6. 12558048 - Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking (2026-02-24),
7. 12555228 - Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking (2026-02-17),
8. 12499539 - Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking (2025-12-16),
9. 12440180 - Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination (2025-10-14),
10. 12406365 - Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination (2025-09-02),
11. 12396695 - Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking (2025-08-26),
12. 12380560 - Systems, methods, and devices for image-based plaque analysis and risk determination (2025-08-05),
13. 12324696 - Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination (2025-06-10),
14. 12324695 - Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking (2025-06-10),
15. 12299885 - Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination (2025-05-13),
CLEERLY, INC. is a cutting-edge technology company specializing in the development of innovative software solutions. With a focus on creating intuitive and intelligent software for businesses of all sizes, CLEERLY aims to streamline processes, enhance productivity, and drive growth. Through their advanced algorithms and data-driven approach, CLEERLY's solutions provide valuable insights and optimize decision-making for their clients. To learn more about CLEERLY and their ground-breaking software solutions, visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Cleerly, Inc.
71 Patents

#21 in Denver, CO

#109 in Colorado

#5,156 in US

#10,478 in the World

Denver, CO (US)
Denver, CO, United States of America

Cleerly, Inc.

Forward Citations = 1,761

9 inventors:

goldMedal James K Min (70 out of 80 patents)

silverMedal James P Earls (59 out of 59 patents)

bronzeMedal Hugo Miguel Rodrigues Marques (57 out of 57 patents)

4.  Ben Hootnick (21 out of 21 patents)

5.  Shant Malkasian (12 out of 12 patents)

Please report any incorrect information to [email protected]
Loading…